Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SCNI | AZN | AMGN | GILD | BMY |
| Company | Scinai Immunotherapeutics Ltd ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.9540 | 94.47 | 328.70 | 123.80 | 56.46 |
| High | 0.9541 | 94.52 | 331.60 | 125.07 | 56.56 |
| Low | 0.9091 | 93.51 | 326.90 | 122.10 | 55.42 |
| Latest | 0.9121 | 94.29 | 331.09 | 124.31 | 55.51 |
| Change | +0.0029 | +0.30 | +1.06 | +3.05 | -1.11 |
| % Change | +0.32% | +0.32% | +0.32% | +2.52% | -1.96% |
| Volume | 14,911 | 4,786,146 | 1,298,869 | 2,709,868 | 4,862,125 |
| 20-Day Average Volume | 42,326 | 5,340,677 | 2,611,039 | 6,003,576 | 13,844,383 |
| Previous Close | 0.9092 | 93.99 | 330.03 | 121.26 | 56.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7843 | 93.08 | 329.12 | 122.86 | 54.91 |
| 20-Day Raw Stochastic | 84.02% | 59.31% | 47.75% | 66.57% | 67.97% |
| 20-Day Relative Strength | 49.70 | 55.77 | 52.53 | 52.41 | 59.91 |
| Weighted Alpha | -60.02 | +42.89 | +21.90 | +30.73 | +7.12 |
| Today's Opinion | 80% Sell | 100% Buy | 64% Buy | 72% Buy | 100% Buy |
| Previous Opinion | 80% Sell | 100% Buy | 80% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.70% since 01/09/26 | -1.04% since 01/09/26 | +1.22% since 01/09/26 | +2.30% since 01/09/26 | -0.74% since 01/09/26 |
| Low | 0.7625 on 01/12/26 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 55.33 on 01/15/26 |
| High | 0.9690 on 01/14/26 | 96.43 on 01/14/26 | 332.50 on 01/15/26 | 125.07 on 01/16/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | +8.60% since 12/16/25 | +2.54% since 12/16/25 | +1.02% since 12/16/25 | +4.30% since 12/16/25 | +2.24% since 12/16/25 |
| Low | 0.6130 on 12/29/25 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 0.9690 on 01/14/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | -37.53% since 10/16/25 | +11.74% since 10/16/25 | +11.58% since 10/16/25 | +5.13% since 10/16/25 | +27.78% since 10/16/25 |
| Low | 0.6130 on 12/29/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 1.5500 on 11/03/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | -57.77% since 07/16/25 | +33.66% since 07/16/25 | +10.38% since 07/16/25 | +12.78% since 07/16/25 | +17.54% since 07/16/25 |
| Low | 0.6130 on 12/29/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 3.4800 on 07/29/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,898 | 291,505,472 | 177,714,880 | 150,444,864 | 115,264,336 |
| Shares Outstanding, K | 3,188 | 3,101,452 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 660,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | 4,800,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 210,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -11,820,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 1.72 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -10.40 on 05/07/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 05/06/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.08 | 15.04 | 15.15 | 8.69 |